subject area of
- Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV‐infected, therapy‐naïve patients: results of the EPIC study (CCR100136)* Journal Articles
- Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis Journal Articles
- Hypofibrinolytic State in HIV-1–Infected Patients Treated With Protease Inhibitor–Containing Highly Active Antiretroviral Therapy Journal Articles
- Milk thistle and indinavir: a randomized controlled pharmacokinetics study and meta-analysis Journal Articles
- NOD2 Activation Induces Muscle Cell-Autonomous Innate Immune Responses and Insulin Resistance Journal Articles
- Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine Journal Articles
- Randomized Controlled Trial of Once-Daily Tenofovir, Lamivudine, and Lopinavir/Ritonavir Versus Remaining on the Same Regimen in Virologically Suppressed HIV-Infected Patients on Their First PI-Containing HAART Regimen Journal Articles
- Synergistic binding of inhibitors to the protease from HIV type 1 Journal Articles
- Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings Journal Articles
- Triple nucleoside treatment with abacavir plus the lamivudine/ zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: results of a 48-week open-label, equivalence trial (CNA3014) Journal Articles